Interestingly, reduced HIF-1α and HIF-1β expression have been observed in the islets of individuals with type 2 diabetes, suggesting that islet HIF-1 inhibition may be a pathogenic mechanism in type 2 diabetes [38, 40]. The gene discussed is HIF1A; the disease is type 2 diabetes mellitus.